iPSCs-Derived Platform: A Feasible Tool for Probing the Neurotropism of SARS-CoV-2

ACS Chem Neurosci. 2020 Sep 2;11(17):2489-2491. doi: 10.1021/acschemneuro.0c00512. Epub 2020 Aug 25.

Abstract

Coronavirus Disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a severe public health problem with a high rate of morbidity and mortality. A mounting number of clinical investigations illustrate that COVID-19 patients suffer from neurologic conditions in addition to respiratory symptoms. In a recent article, Yuen and colleagues present the first experimental evidence of SARS-CoV-2 infection in the human central nervous system using induced pluripotent stem cells (iPSCs)-derived platform including human neural progenitor cells, neurospheres, and three-dimensional brain organoids (Yuen, K.Y., and Huang, J.D. et al. (2020) Cell Res. DOI: 10.1038/s41422-020-0390-x).

Keywords: SARS-CoV-2; brain infection; human neural progenitor cell; iPSCs; neurosphere; organoid.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Betacoronavirus*
  • Brain / pathology*
  • Brain / virology
  • COVID-19
  • Coronavirus Infections / pathology*
  • Coronavirus Infections / transmission*
  • Feasibility Studies
  • Humans
  • Induced Pluripotent Stem Cells / pathology*
  • Induced Pluripotent Stem Cells / virology
  • Organoids / pathology
  • Organoids / virology
  • Pandemics
  • Pneumonia, Viral / pathology*
  • Pneumonia, Viral / transmission*
  • SARS-CoV-2